PHN.WA(PHN.WA)
PHN.WA
No analyst ratings available
No analyst price targets available for PHN.WA
Analyst coverage may not be available for this symbol
No recent analyst actions
| Metric | FY2026E | FY2027E |
|---|---|---|
| Revenue Avg | $802M | $870M |
| Low | $802M | $870M |
| High | $802M | $870M |
| EBITDA Avg | $186M | $202M |
| Low | $186M | $202M |
| High | $186M | $202M |
| EBIT Avg | $176M | $191M |
| Low | $176M | $191M |
| High | $176M | $191M |
| Net Income Avg | $30M | $31M |
| Low | $30M | $31M |
| High | $30M | $31M |
| EPS Avg | $0.58 | $0.61 |
| Low | $0.58 | $0.61 |
| High | $0.58 | $0.61 |
| Analysts (Rev / EPS) | 1 / 1 | 1 / 1 |
| Metric | Q3 2026 | Q4 2026 | Q1 2027 | Q2 2027 | Q3 2027 | Q4 2027 | Q1 2028 | Q2 2028 |
|---|---|---|---|---|---|---|---|---|
| Revenue Avg | $109M | $109M | $108M | $108M | $112M | $138M | $73M | $65M |
| Low | $109M | $109M | $108M | $108M | $112M | $138M | $73M | $65M |
| High | $109M | $109M | $108M | $108M | $112M | $138M | $73M | $65M |
| EBITDA Avg | $25M | $25M | $25M | $25M | $26M | $32M | $17M | $15M |
| Low | $25M | $25M | $25M | $25M | $26M | $32M | $17M | $15M |
| High | $25M | $25M | $25M | $25M | $26M | $32M | $17M | $15M |
| EBIT Avg | $24M | $24M | $24M | $24M | $25M | $30M | $16M | $14M |
| Low | $24M | $24M | $24M | $24M | $25M | $30M | $16M | $14M |
| High | $24M | $24M | $24M | $24M | $25M | $30M | $16M | $14M |
| Net Income Avg | — | — | — | — | — | — | — | — |
| Low | — | — | — | — | — | — | — | — |
| High | — | — | — | — | — | — | — | — |
| EPS Avg | — | — | — | — | — | — | — | — |
| Low | — | — | — | — | — | — | — | — |
| High | — | — | — | — | — | — | — | — |
| Analysts (Rev / EPS) | 1 / — | 1 / — | 1 / — | 1 / — | 1 / — | 1 / — | 1 / — | 1 / — |